Rexford Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Sell
7,776
-150
-2% -$20.7K 0.7% 40
2026
Q2
$1.02M Buy
7,926
+24
+0.3% +$2.81K 0.62% 44
2026
Q1
$951K Buy
7,902
+103
+1% +$11.9K 0.68% 43
2025
Q4
$821K Buy
7,799
+100
+1% +$9.39K 0.62% 49
2025
Q3
$646K Hold
7,699
– – 0.5% 61
2025
Q2
$609K Buy
+7,699
New +$612K 0.51% 61

Other funds holding MRK

Rexford Capital's MRK Position: Q3 2026 in Review

Rexford Capital reduced its Merck (MRK) stake by 1.9% in Q3 2026, selling an estimated $20.7K and leaving 7,776 shares worth $1.13M. The position accounts for 0.7% of the portfolio, ranked #40.

Rexford Capital first reported a position in MRK in Q2 2025 and has held it in 6 quarters since. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Rexford Capital held 7,776 shares of Merck worth $1.13M as of Q3 2026.
  • Rexford Capital sold 150 Merck shares in Q3 2026, an estimated $20.7K.
  • Merck made up 0.7% of Rexford Capital's portfolio in Q3 2026, its #40 holding.
  • Rexford Capital first reported a position in Merck in Q2 2025 and has held it in 6 quarters since.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Rexford Capital's 13F filing for Q3 2026, filed 13 Nov 2026.